These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8139042)

  • 1. Spontaneous substitutions in the vicinity of the V3 analog affect cell tropism and pathogenicity of simian immunodeficiency virus.
    Hirsch VM; Martin JE; Dapolito G; Elkins WR; London WT; Goldstein S; Johnson PR
    J Virol; 1994 Apr; 68(4):2649-61. PubMed ID: 8139042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive envelope heterogeneity of simian immunodeficiency virus in tissues from infected macaques.
    Campbell BJ; Hirsch VM
    J Virol; 1994 May; 68(5):3129-37. PubMed ID: 8151778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte-tropic simian immunodeficiency virus causes persistent infection in the brains of rhesus monkeys.
    Stephens EB; Liu ZQ; Zhu GW; Adany I; Joag SV; Foresman L; Berman NE; Narayan O
    Virology; 1995 Nov; 213(2):600-14. PubMed ID: 7491784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cell-free stock of simian-human immunodeficiency virus that causes AIDS in pig-tailed macaques has a limited number of amino acid substitutions in both SIVmac and HIV-1 regions of the genome and has offered cytotropism.
    Stephens EB; Mukherjee S; Sahni M; Zhuge W; Raghavan R; Singh DK; Leung K; Atkinson B; Li Z; Joag SV; Liu ZQ; Narayan O
    Virology; 1997 May; 231(2):313-21. PubMed ID: 9168893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ITAM in Nef influences acute pathogenesis of AIDS-inducing simian immunodeficiency viruses SIVsm and SIVagm without altering kinetics or extent of viremia.
    Dehghani H; Brown CR; Plishka R; Buckler-White A; Hirsch VM
    J Virol; 2002 May; 76(9):4379-89. PubMed ID: 11932405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population.
    Rudensey LM; Kimata JT; Benveniste RE; Overbaugh J
    Virology; 1995 Mar; 207(2):528-42. PubMed ID: 7886956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition.
    Rudensey LM; Kimata JT; Long EM; Chackerian B; Overbaugh J
    J Virol; 1998 Jan; 72(1):209-17. PubMed ID: 9420217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.
    Kuwata T; Dehghani H; Brown CR; Plishka R; Buckler-White A; Igarashi T; Mattapallil J; Roederer M; Hirsch VM
    J Virol; 2006 Feb; 80(3):1463-75. PubMed ID: 16415023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid change in gp41 is linked to the macrophage-only replication phenotype of a molecular clone of simian immunodeficiency virus derived from the brain of a macaque with neuropathogenic infection.
    Glenn AA; Novembre FJ
    Virology; 2004 Aug; 325(2):297-307. PubMed ID: 15246269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simian human immunodeficiency virus with a nonfunctional Vpu (deltavpuSHIV(KU-1bMC33)) isolated from a macaque with neuroAIDS has selected for mutations in env and nef that contributed to its pathogenic phenotype.
    Singh DK; McCormick C; Pacyniak E; Lawrence K; Dalton SB; Pinson DM; Sun F; Berman NE; Calvert M; Gunderson RS; Wong SW; Stephens EB
    Virology; 2001 Mar; 282(1):123-40. PubMed ID: 11259196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
    Igarashi T; Donau OK; Imamichi H; Dumaurier MJ; Sadjadpour R; Plishka RJ; Buckler-White A; Buckler C; Suffredini AF; Lane HC; Moore JP; Martin MA
    J Virol; 2003 Dec; 77(24):13042-52. PubMed ID: 14645561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of a neuropathogenic simian immunodeficiency virus derived from a sooty mangabey.
    Novembre FJ; De Rosayro J; O'Neil SP; Anderson DC; Klumpp SA; McClure HM
    J Virol; 1998 Nov; 72(11):8841-51. PubMed ID: 9765429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of simian immunodeficiency virus Mne variants upon transmission.
    Chackerian B; Morton WR; Overbaugh J
    J Virol; 1994 Jun; 68(6):4080-5. PubMed ID: 8189548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence variation in the env gene of simian immunodeficiency virus recovered from immunized macaques is predominantly in the V1 region.
    Almond N; Jenkins A; Heath AB; Kitchin P
    J Gen Virol; 1993 May; 74 ( Pt 5)():865-71. PubMed ID: 8492090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique pattern of convergent envelope evolution in simian immunodeficiency virus-infected rapid progressor macaques: association with CD4-independent usage of CCR5.
    Dehghani H; Puffer BA; Doms RW; Hirsch VM
    J Virol; 2003 Jun; 77(11):6405-18. PubMed ID: 12743298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.
    Clements JE; Montelaro RC; Zink MC; Amedee AM; Miller S; Trichel AM; Jagerski B; Hauer D; Martin LN; Bohm RP
    J Virol; 1995 May; 69(5):2737-44. PubMed ID: 7707496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac.
    Marthas ML; Ramos RA; Lohman BL; Van Rompay KK; Unger RE; Miller CJ; Banapour B; Pedersen NC; Luciw PA
    J Virol; 1993 Oct; 67(10):6047-55. PubMed ID: 8371353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally.
    Amedee AM; Lacour N; Gierman JL; Martin LN; Clements JE; Bohm R; Harrison RM; Murphey-Corb M
    J Virol; 1995 Dec; 69(12):7982-90. PubMed ID: 7494311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.
    Means RE; Matthews T; Hoxie JA; Malim MH; Kodama T; Desrosiers RC
    J Virol; 2001 Apr; 75(8):3903-15. PubMed ID: 11264379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
    McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
    Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.